Pier 88 Investment Partners LLC Krystal Biotech, Inc. Transaction History
Pier 88 Investment Partners LLC
- $87 Million
- Q2 2024
A detailed history of Pier 88 Investment Partners LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 3,360 shares of KRYS stock, worth $579,700. This represents 0.71% of its overall portfolio holdings.
Number of Shares
3,360
Previous 1,170
187.18%
Holding current value
$579,700
Previous $208,000
196.63%
% of portfolio
0.71%
Previous 0.33%
Shares
2 transactions
Others Institutions Holding KRYS
# of Institutions
274Shares Held
24.9MCall Options Held
270KPut Options Held
172K-
Black Rock Inc. New York, NY3.95MShares$681 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.87MShares$495 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.43MShares$420 Million6.1% of portfolio
-
State Street Corp Boston, MA1.33MShares$230 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA1.02MShares$176 Million12.22% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.43B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...